Targeting Neuroinflammation in Brain Cancer: Uncovering Mechanisms, Pharmacological Targets, and Neuropharmaceutical Developments
Gliomas are one of the most lethal types of cancers accounting for ∼80% of all central nervous system (CNS) primary malignancies. Among gliomas, glioblastomas (GBM) are the most aggressive, characterized by a median patient survival of fewer than 15 months. Recent molecular characterization studies...
Những tác giả chính: | Mahmoud S. Alghamri, Brandon L. McClellan, Carson S. Hartlage, Santiago Haase, Syed Mohd Faisal, Rohit Thalla, Ali Dabaja, Kaushik Banerjee, Stephen V. Carney, Anzar A. Mujeeb, Michael R. Olin, James J. Moon, Anna Schwendeman, Pedro R. Lowenstein, Maria G. Castro |
---|---|
Định dạng: | Bài viết |
Ngôn ngữ: | English |
Được phát hành: |
Frontiers Media S.A.
2021-05-01
|
Loạt: | Frontiers in Pharmacology |
Những chủ đề: | |
Truy cập trực tuyến: | https://www.frontiersin.org/articles/10.3389/fphar.2021.680021/full |
Những quyển sách tương tự
-
Murine brain tumor microenvironment immunophenotyping using mass cytometry
Bằng: Brandon L. McClellan, et al.
Được phát hành: (2022-06-01) -
Impact of epigenetic reprogramming on antitumor immune responses in glioma
Bằng: Brandon L. McClellan, et al.
Được phát hành: (2023-01-01) -
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies
Bằng: Maria B. Garcia-Fabiani, et al.
Được phát hành: (2021-06-01) -
Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment
Bằng: Andrea Franson, et al.
Được phát hành: (2022-09-01) -
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models
Bằng: Santiago Haase, et al.
Được phát hành: (2022-11-01)